Cargando…

Targeting ovarian cancer stem cells: a new way out

Ovarian cancer (OC) is the most lethal gynecological malignancy due to tumor heterogeneity, the lack of reliable early diagnosis methods and the high incidence of chemoresistant recurrent disease. Although there are developments in chemotherapies and surgical techniques to improve the overall surviv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Huiying, Tian, Tian, Cui, Zhumei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926632/ https://www.ncbi.nlm.nih.gov/pubmed/36788591 http://dx.doi.org/10.1186/s13287-023-03244-4

Ejemplares similares

The viable circulating tumor cells with cancer stem cells feature, where is the way out?
por: Luo, Y. T., et al.
Publicado: (2018)

Are ovarian cancer stem cells the target for innovative immunotherapy?
por: Wang, Liang, et al.
Publicado: (2018)

Ovarian Cancer Stem Cells: A New Target for Cancer Therapy
por: Zhan, Qinglei, et al.
Publicado: (2013)

S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin
por: Wang, Lingzhi, et al.
Publicado: (2019)

Linc-ROR induces epithelial-to-mesenchymal transition in ovarian cancer by increasing Wnt/β-catenin signaling
por: Lou, Yanhui, et al.
Publicado: (2017)

Ovarian cancer stem cells and targeted therapy
por: Keyvani, Vahideh, et al.
Publicado: (2019)

Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells
por: Yang, Wookyeom, et al.
Publicado: (2021)

Interconnected Adaptive Responses: A Way Out for Cancer Cells to Avoid Cellular Demise
por: D’Orazi, Gabriella, et al.
Publicado: (2022)

Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer
por: Muñoz-Galván, Sandra, et al.
Publicado: (2020)

Glycolytic cancer cells splice their way out of trouble
por: Sedwick, Caitlin
Publicado: (2015)

BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity
por: Liu, Junxiu, et al.
Publicado: (2022)

Ways Out of the Patenting Prohibition? Human Parthenogenetic and Induced Pluripotent Stem Cells
por: Schickl, Hannah, et al.
Publicado: (2017)

Out of harm's way
Publicado: (1985)

No Easy Way Out (Or in)
por: De Weer, Paul
Publicado: (1999)

Way out basie
por: Wilkins, Ernie
Publicado: (1999)

Stem-like features of cancer cells on their way to metastasis
por: Gkountela, Sofia, et al.
Publicado: (2016)

Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting
por: Zong, Xingyue, et al.
Publicado: (2019)

Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
por: Deng, Junli, et al.
Publicado: (2016)

Osteosarcopenia and Pain: Do We Have a Way Out?
por: Bonanni, Roberto, et al.
Publicado: (2023)

Nanotechnology and Glycosaminoglycans: Paving the Way Forward for Ovarian Cancer Intervention
por: Hoosen, Yasar, et al.
Publicado: (2018)

Targeting KRAS in PDAC: A New Way to Cure It?
por: He, Qianyu, et al.
Publicado: (2022)

The Evolving Landscape of Cancer Stem Cells and Ways to Overcome Cancer Heterogeneity
por: Taniguchi, Hiroaki, et al.
Publicado: (2019)

CAR-T Cells in the Treatment of Ovarian Cancer: A Promising Cell Therapy
por: Zhang, Xi-Wen, et al.
Publicado: (2023)

S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial–mesenchymal transition
por: Tian, Tian, et al.
Publicado: (2017)

Drug Treatment of Cancer Cell Lines: A Way to Select for Cancer Stem Cells?
por: Chiodi, Ilaria, et al.
Publicado: (2011)

New perspectives on targeted therapy in ovarian cancer
por: Coward, Jermaine IG, et al.
Publicado: (2015)

Targeting Prostate Cancer, the ‘Tousled Way’
por: Bhoir, Siddhant, et al.
Publicado: (2023)

Osteosarcoma Pathogenesis Leads the Way to New Target Treatments
por: Fernandes, Isabel, et al.
Publicado: (2021)

New ways of assessing ovarian cancer response: metabolic imaging and beyond
por: Rockall, Andrea, et al.
Publicado: (2012)

The Chancellor's Difficulties and a Way out
Publicado: (1915)

Serum Levels of S100A11 and MMP-9 in Patients with Epithelial Ovarian Cancer and Their Clinical Significance
por: Li, Wenjing, et al.
Publicado: (2021)

Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism
por: Li, Shan-Shan, et al.
Publicado: (2018)

Development of New Technologies for Stem Cell Research
por: Ma, Xibo, et al.
Publicado: (2012)

Notch3 Targeting: A Novel Weapon against Ovarian Cancer Stem Cells
por: Ceccarelli, Simona, et al.
Publicado: (2019)

Ovarian Epithelial Cancer Stem Cells
por: Conic, Irena, et al.
Publicado: (2011)

Partners in Crime: Towards New Ways of Targeting Calcium Channels
por: Noyer, Lucile, et al.
Publicado: (2019)

Starting out in shares the ASX way
por: Wrightbooks
Publicado: (2015)

Neutrophils take the easy way out
por: Van Epps, Heather L.
Publicado: (2006)

Presence and role of stem cells in ovarian cancer
por: Kenda Suster, Natasa, et al.
Publicado: (2019)

Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies
por: Wilczyński, Jacek R, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qj5p7190rgm72l9j8a5edu0ulf